Reply to thread

Message: <blockquote data-quote="Simon7" data-source="post: 140155" data-attributes="member: 14795">[USER=18023]@DragonBits[/USER] , thank you for that very informative post about the differences of HCT rises via different Testosterone delivery systems. I live outside the US and I've tried both Nebido and transdermal gel but as I have low SHBG the T gets quickly flushed out of my system. What enables me to sustain continuous high T levels is bi weekly SUBQ T enanthate injections, which are absorbed slower via the SUBQ tissue. However the T enanthate does raise my HCT, requiring me to donate blood three times a year.I wonder if the Nebido 1000mg/4ml dose can be  split up used in bi weekly SUBQ injections of say 50mg each, thus lasting 10 weeks, similar to what I do with my T ethanoate ampule. The <a href="https://www.medicines.org.uk/emc/product/3873/smpc" target="_blank">Nebido instructions</a> state:"As with all oily solutions, Nebido must be injected strictly intramuscularly and very slowly (over two minutes). Pulmonary microembolism of oily solutions can in rare cases lead to signs and symptoms such as cough, dyspnoea, malaise, hyperhidrosis, chest pain, dizziness, paraesthesia, or syncope. These reactions may occur during or immediately after the injection and are reversible. The patient should therefore be observed during and immediately after each injection in order to allow for early recognition of possible signs and symptoms of pulmonary oily microembolism. Treatment is usually supportive, e.g. by administration of supplemental oxygen.Suspected anaphylactic reactions after Nebido injection have been reported."The question is given the above warning of Pulmonary microembolism is  would it be safe to home administer Nebido via SUBQ. Unless a medical authority says it is safe I would not attempt it. Perhaps [USER=12687]@Dr Justin Saya MD[/USER] can chime in?</blockquote>

Verification

Share this page

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Sponsors

We value your privacy

We use essential cookies to make this site work, and optional cookies to enhance your experience.

See further information and configure your preferences

Accept all cookies Reject optional cookies
Essential cookies

These cookies are required to enable core functionality such as security, network management, and accessibility. You may not reject these.

Optional cookies

We deliver enhanced functionality for your browsing experience by setting these cookies. If you reject them, enhanced functionality will be unavailable.

Third-party cookies

Cookies set by third parties may be required to power functionality in conjunction with various service providers for security, analytics, performance or advertising purposes.

Detailed cookie usage

Privacy policy

Reply to thread

Share this page

Sponsors

We value your privacy